Holen Sie sich die Stockscreener-App
2.55
2.67%
-0.07
Handel nachbörslich:
2.62
0.07
+2.75%
Schlusskurs vom Vortag:
$2.62
Offen:
$2.6
24-Stunden-Volumen:
19,208
Relative Volume:
0.33
Marktkapitalisierung:
$7.35M
Einnahmen:
$77,900
Nettoeinkommen (Verlust:
$-8.05M
KGV:
-0.2763
EPS:
-9.2296
Netto-Cashflow:
$-7.47M
1W Leistung:
+5.37%
1M Leistung:
+3.66%
6M Leistung:
-20.81%
1J Leistung:
-66.75%
1-Tages-Spanne:
$2.51
$2.62
1-Wochen-Bereich:
$2.4001
$2.64
52-Wochen-Spanne:
$1.95
$12.03
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, BTSG, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.55 | 7.49M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
264.90 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
69.97 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
58.96 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
72.68 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.00 | 7.96B | 1.34B | 230.70M | 440.96M | 2.6695 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
ACON Q2 2026 Earnings: Wider -$1.12 Per-Share Loss Sends Shares Down 4.76%Negative Surprise Momentum - vinanet.vn
Aclarion Inc. (ACON) Slips 4.76% to $2.4 as Key Support Level Comes into FocusSweep Order Flow - dars.gov.et
Aclarion Inc (ACONW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Aclarion (ACONW) Stock: Holds Near $0.03 in the Latest Reading; Chart View - vinanet.vn
Aclarion (ACON) Outlook: Moves 0.74% Higher to $2.71 on the Day; Price Setup: Traders Can Monitor the $2.57-$2.85 Range in Latest TradingIndex Put Call - vinanet.vn
Aclarion (ACON) Upgraded to Buy: Here's Why - Eastern Progress
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACON - TradingView
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - Orthopedics This Week
AclarionAnticipates Having Initial Interna - Moomoo
Aclarion adds University of Arizona to Nociscan spine trial By Investing.com - Investing.com Australia
Aclarion adds University of Arizona to Nociscan spine trial - Investing.com
Aclarion Announces Addition of University of Arizona College of MedicinePhoenix as CLARITY Trial Site - The Manila Times
Aclarion's 300-patient back-pain study now has 10 enrolling sites - Stock Titan
Aclarion (ACON) EPS and Revenue: The Available Earnings Metric Delivers a Miss in Latest Trading; After Results: The Stock Gains 6.54% on the DayROIC Trend Report - vinanet.vn
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com
Top Aclarion Executive Makes Bold Insider Move on Company Stock - TipRanks
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Nigeria
Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayHealthcare Earnings Report - vinanet.vn
ACON | Aclarion, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com
Major Insider Buying Spree Signals Strong Confidence in This Tech Stock - TipRanks
Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Ryan Bond buys $50,059 in ACON shares By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock - Investing.com
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com
Aclarion (ACON) director lifts stake to 23,713 shares - Stock Titan
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et
Aclarion receives patent allowance for MRI scan technology By Investing.com - Investing.com Nigeria
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - The Manila Times
Aclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc Evaluation - Quiver Quantitative
Aclarion receives patent allowance for MRI scan technology - Investing.com
Aclarion Inc. (ACON) Slips 3.39% as Shares Approach Key $2.17 SupportTake Profit Levels - vinanet.vn
Aclarion, Inc. Revenue Breakdown – FWB:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – BOATS:ACONW - TradingView
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingView
Aclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock Titan
Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - Bitget
Aclarion Inc. Warrant (ACONW) Slips 2.39% but Remains Supported at $0.02Resistance Breakout Stocks - dars.gov.et
Aclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20Strong Buy Stocks - dars.gov.et
Aclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver Quantitative
Aclarion, Inc Announces Nociscan Now Available At Goodman Campbell Brain & Spine At Ascension St. Vincent - marketscreener.com
Aclarion's Nociscan tech for chronic low back p... - Pluang
Aclarion Inc. Warrant (ACONW) Surges 35% to $0.03, Trading at Critical JunctureETF Inflow Streak - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds at $0.02 as Trading Range Compresses to a PointFibonacci Retracement - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds Steady at $0.02 as Trading Range CompressesNew Listing Stocks - dars.gov.et
ACON Q1 2026 Earnings: Narrower-than-Expected Loss Beats by 15.24%, Shares Advance 11.39%Full Year Guidance - vinanet.vn
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aclarion Inc-Aktie (ACON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gould Gregory A | CFO |
Aug 14 '26 |
Buy |
2.45 |
10,000 |
24,500 |
60,000 |
| Bond Ryan | Director |
Aug 13 '26 |
Buy |
2.37 |
21,122 |
50,059 |
76,122 |
| Wesemann William | Director |
Aug 13 '26 |
Buy |
2.34 |
2,150 |
5,031 |
23,713 |
| Neal David K | Director |
Aug 13 '26 |
Buy |
2.40 |
7,500 |
18,000 |
30,002 |
| Ness Brent | Chief Executive Officer |
Aug 13 '26 |
Buy |
2.31 |
5,234 |
12,091 |
111,534 |
| Breidbart Scott | Director |
May 12 '26 |
Buy |
3.18 |
5,664 |
18,012 |
5,664 |
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
0.15%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):